References
- IASP . Terminology. www.iasp-pain.org/resources/terminology/
- Baron R , BinderA , WasnerG. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol.9, 807–819 (2010).
- van Hecke O , AustinSK , KhanRA , SmithBH , TorranceN. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain155, 654–662 (2014).
- Scholz J , FinnerupNB , AttalNet al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain160, 53–59 (2019).
- Dworkin RH , O’ConnorAB , BackonjaMet al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain132, 237–251 (2007).
- Finnerup NB , AttalN , HaroutounianSet al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol.14, 162–173 (2015).
- Deng Y , LuoL , HuY , FangK , LiuJ. Clinical practice guidelines for the management of neuropathic pain: a systematic review. BMC Anesthesiol.16, 12 (2016).
- Finnerup NB , HaroutounianS , BaronRet al. Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy. Pain159, 2339–2346 (2018).
- Moisset X , BouhassiraD , CouturierJAet al. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev. Neurol.176, 325–352 (2020).
- Morel V , JolyD , VillatteCet al. Memantine before mastectomy prevents post-surgery pain: a randomized, blinded clinical trial in surgical patients. PLOS ONE11, e0152741 (2016).
- Jiang J , LiY , ShenQet al. Effect of pregabalin on radiotherapy-related neuropathic pain in patients with head and neck cancer: a randomized controlled trial. J. Clin. Oncol.37, 135–143 (2019).
- Pickering G , VouteM , MacianN , GanryH , PereiraB. Effectiveness and safety of 5% lidocaine-medicated plaster on localized neuropathic pain after knee surgery: a randomized, double-blind controlled trial. Pain160, 1186–1195 (2019).
- Jain SM , BalamuruganR , TandonMet al. Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function. Pain163, e738–e747 (2022).
- Kato J , BabaM , KurohaMet al. Safety and efficacy of mirogabalin for peripheral neuropathic pain: pooled analysis of two pivotal Phase III studies. Clin. Ther.43, 822–835.e16 (2021).
- Zakrzewska JM , PalmerJ , MorisettVet al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet Neurol.16, 291–300 (2017).
- Markman J , ResnickM , GreenbergSet al. Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial. J. Neurol.265, 2815–2824 (2018).
- Palladini M , BoeslI , KoenigS , BuchheisterB , AttalN. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial. Curr. Med. Res. Opin.35, 757–766 (2019).
- Kersten C , CameronMG , BaileyAGet al. Relief of neuropathic pain through epidermal growth factor receptor inhibition: a randomized proof-of-concept trial. Pain Med.20, 2495–2505 (2019).
- Bouhassira D , PerrotS , RiantTet al. Safety and efficacy of an equimolar mixture of oxygen and nitrous oxide: a randomized controlled trial in patients with peripheral neuropathic pain. Pain162, 1104–1115 (2021).
- Lipone P , EhlerE , NastajMet al. Efficacy and safety of low doses of trazodone in patients affected by painful diabetic neuropathy and treated with gabapentin: a randomized controlled pilot study. CNS Drugs34, 1177–1189 (2020).
- Cave A , KurzX , ArlettP. Real-world data for regulatory decision making: challenges and possible solutions for Europe. Clin. Pharmacol. Ther.106, 36–39 (2019).
- Dreyer NA , HallM , ChristianJB. Modernizing regulatory evidence with trials and real-world studies. Ther. Innov. Regul. Sci.54, 1112–1115 (2020).
- Eichler HG , PignattiF , Schwarzer-DaumBet al. Randomized controlled trials versus real world evidence: neither magic nor myth. Clin. Pharmacol. Ther.109, 1212–1218 (2021).
- Eichler HG , Bloechl-DaumB , BroichKet al. Data rich, information poor: can we use electronic health records to create a learning healthcare system for pharmaceuticals? Clin. Pharmacol. Ther. 105, 912–922 (2019).
- Eichler HG , KoenigF , ArlettPet al. Are novel, nonrandomized analytic methods fit for decision making? The need for prospective, controlled, and transparent validation. Clin. Pharmacol. Ther.107, 773–779 (2020).
- European Medicines Agency . Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia. www.ema.europa.eu/en/news/repurposing-authorised-medicines-pilot-support-not-profit-organisations-academia
- US Food and Drug Administration . Real-world evidence. www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence
- European Union Innovative Medicines Initiative GetReal project . Glossary of definitions of common terms. www.imi-getreal.eu/Portals/1/Documents/01%20deliverables/D1.3%20-%20Revised%20GetReal%20glossary%20-%20FINAL%20updated%20version_25Oct16_webversion.pdf
- Moore RA , DerryS , WiffenPJ. Challenges in design and interpretation of chronic pain trials. BJA111, 38–45 (2013).
- Moore RA , MooreOA , DerryS , PelosoPM , GammaitoniAR , WangH. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann. Rheum. Dis.69, 374–379 (2010).
- Li M , ChenS , LaiYet al. Integrating real-world evidence in regulatory decision-making process: a systematic analysis of experiences in the US, EU, and China using a logic model. Front. Med.8, 669509 (2021).
- Jaksa A , WuJ , JónssonP , EichlerHG , VititoeS , GattoNM. Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance. J. Comp. Eff. Res.10, 711–731 (2021).
- Franklin JM , LiawKL , IyasuS , CritchlowCW , DreyerNA. Real-world evidence to support regulatory decision making: new or expanded medical product indications. Pharmacoepidemiol. Drug Saf.30, 685–693 (2021).
- European Medicines Agency . Guideline on registry-based studies. www.ema.europa.eu/en/documents/scientific-guideline/guideline-registry-based-studies_en-0.pdf
- European Medicines Agency . Initiation of DARWIN EU® Coordination Centre advances integration of real-world evidence into assessment of medicines in the EU. www.ema.europa.eu/en/news/initiation-darwin-eur-coordination-centre-advances-integration-real-world-evidence-assessment
- Bolislis WR , FayM , KühlerTC. Use of real-world data for new drug applications and line extensions. Clin. Ther.42, 926–938 (2020).
- Feinberg BA , GajraA , ZettlerME , PhillipsTD , PhillipsEG , KishJK. Use of real-world evidence to support FDA approval of oncology drugs. Value Health23, 1358–1365 (2020).
- US Food and Drug Administration . FDA approves new use of transplant drug based on real-world evidence. www.fda.gov/drugs/news-events-human-drugs/fda-approves-new-use-transplant-drug-based-real-world-evidence#:~:text=FDA%20approves%20new%20use%20of%20transplant%20drug%20based%20on%20real%2Dworld%20evidence,-Sharet&text=Today%2C%20the%20U.S.%20Food%20and,evidence%20(RWE)%20of%20effectiveness
- Quessy SN , RowbothamMC. Placebo response in neuropathic pain trials. Pain138, 479–483 (2008).
- Boussageon R , HowickJ , BaronRet al. How do they add up? The interaction between the placebo and treatment effect: a systematic review. Br. J. Clin. Pharmacol. doi:10.1111/bcp.15345 (2022) ( Epub ahead of print).
- Bischoff JM , RingstedTK , PetersenM , SommerC , ÜçeylerN , WernerMU. A capsaicin (8%) patch in the treatment of severe persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled trial. PLOS ONE9, e109144 (2014).
- Howard JP , WoodFA , FinegoldJAet al. Side effect patterns in a crossover trial of statin, placebo, and no treatment. J. Am. Coll. Cardiol.78, 1210–1222 (2021).
- Institut Analgesia . eDOL, an e-health application. www.institut-analgesia.org/portfolio-item/edol-an-e-health-application/?lang=en
- Moisset X , PagéMG , PereiraB , ChoinièreM. Pharmacological treatments of neuropathic pain: real-life comparisons using propensity score matching. Pain163, 964–974 (2022).
- Überall MA , BöslI , HollandersE , SabatschusI , EerdekensM. Localized peripheral neuropathic pain – topical treatment with lidocaine 700 mg medicated plaster in routine clinical practice. Pain Manag.12, 521–533 (2022).
- Schlereth T . Guideline “diagnosis and non interventional therapy of neuropathic pain” of the German Society of Neurology (deutsche Gesellschaft für Neurologie). Neurol. Res. Pract.2, 16 (2020).
- National Institute for Health and Care Excellence . Neuropathic pain in adults: pharmacological management in non-specialist settings. Clinical guideline [CG173]; published: 20 November 2013; last updated: 22 September 2020. www.nice.org.uk/guidance/cg173/chapter/1-recommendations
- Liu M , QiY , WangW , SunX. Toward a better understanding about real-world evidence. Eur. J. Hosp. Pharm.29, 8–11 (2022).
- Mick G , SerpellM , BaronRet al. Localised neuropathic pain in the primary care setting: a cross-sectional study of prevalence, clinical characteristics, treatment patterns, quality of life and sleep performance. Curr. Med. Res. Opin.37, 293–302 (2021).